New research published in Scientific Reports details the accuracy of optical microscope technology in identifying malignant brain tumors.

Researchers found that incorporating lung nodule features and patient-specific characteristics improved the positive predictive ability of a cancer screening model while maintaining low-dose CT scan sensitivity, according to research published in the Journal of the American College of Radiology.

German and Russian researchers have developed a new injection diagnosis system based on magnetoferritin that may improve MRI accuracy, cancer diagnosis and treatment options.

The U.S. Preventative Services Task Force (USPSTF) issued updated cervical cancer screening guidelines Aug. 21 that stated a human papillomavirus (HPV) test alone is as effective as the commonly used Pap smear.

Veterans who utilize Medicare and other fee-for-service health systems for prostate cancer care are more likely to receive guideline-discordant imaging than those treated at the Veterans Health Administration (VA), according to a study published Aug. 17 in JAMA Network Open.

“Treatment effect is more reliably determined on imaging at 90 days following SIRT, however imaging at one-month post-SIRT is still frequently performed,” Shamar Young, MD, and colleagues wrote. “This raises the question as to whether or not imaging at one month following SIRT is clinically warranted.”

While heart failure (HF) is an uncommon complication of breast cancer, a new study in the Journal of the American College of Cardiology notes individuals treated with trastuzumab-based chemotherapy have a higher risk for HF—but they are not monitored for it, despite recommendations.

Cancer screening rates in the U.S. over the past 15 years remain short of national goals, according to new analysis performed by the Centers for Disease Control and Prevention (CDC).